COVID-19: Funding opportunities

Below are current COVID-19 related funding opportunities and updates. We will update this site as we receive new information.

For all other COVID-19 updates related to research refer to the UVic Research COVID-19 webpage.

Canada Research Continuity Emergency Fund

The Canada Research Continuity Emergency Fund (CRCEF) was announced on May 15, 2020, as part of the Government of Canada’s COVID-19 Economic Response Plan.

Tri-agency updates

For the most up-to-date information related to COVID-19 please check the agencies' website:

Other resources

Funding opportunities

BioTalent Canada Student/Graduate Wage Subsidy Programs (ongoing)

Details: BioTalent Canada wage subsidy programs provide financial support to bio-economy employers to reduce the risk of hiring talent and to provide additional support employers during the COVID-19 crisis. Programs include the Student Work Placement Program, the Science Horizons Youth Internship program for recent graduates and the Science and Technology Internship Program to facilitate the transition of barriered youth into the labour market.

Award: $5,000 - $32,000 in wage subsidies for 3 - 12 months placements depending on program

Full details and application process

Emergent Ventures Fast Grants for COVID-19 (ongoing)

Details: Aims to jump-start high-risk, high-reward ideas that advance prosperity, opportunity, and wellbeing. The fellowship provides participants with the short-term resources and support to quickly develop and test their ideas. Fast grants are available for scientists in an academic institution currently working on a COVID-19 related project.

In addition to financial support, participants will have access to mentors and networks in the George Mason community, such as Mercatus’ faculty director, Tyler Cowen, and industry leaders across the country. Emergent Ventures is looking to make a bet on talented individuals with unique ideas for changing the world.

Award: Fast Grants are valued at $10,000 - $500,000 and decisions are made in under 14 days.

Full details and application process

For scientific or biomedical COVID-19 projects, please apply through (Note: This stream is currently paused due to receipt of a large number of qualified submissions. It may reopen in the future.)

For non-scientific/biomedical COVID-19 projects, please apply through the Emergent Ventures application.

Compute Canada Federation - COVID-19 resource support (ongoing)

Details: Compute Canada Federation are offering support for researchers working on COVID-19 related projects. Support could include: 

  • providing access to cloud resources, high-performance clusters, storage or boosting job priority;
  • consulting on high-performance computing (HPC), data analysis, machine learning, and visualization; and 
  • connecting your researchers to Canadian scientists from other research areas and institutions to further collaborations.

Full details and application process

To access any of these resources, please email with “COVID-19” in the subject line. 


NIH: Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration (various deadlines)

Details: This Notice of Special Interest issued by the National Institute on Aging (NIA) seeks to support basic and clinical mechanistic research on neurological and neurocognitive sequelae originating from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) in aging and age-related neurodegeneration.

The opportunity will be open until May 8, 2023 with multiple application deadlines, the first on June 5, 2021. Foreign institutions are eligible to apply either as a lead institution or in collaboration with a US partner.


Although SARS-CoV-2 infection poses a risk at all ages, adults aged 65 years and older are at greatest risk of severe disease, hospitalization, intensive care use, and death. Older adults are more likely to have one or more underlying diseases and conditions associated with worse outcomes from SARS-CoV-2 infection, including diabetes, coronary artery disease, pulmonary disease and other organ dysfunction, neurodegenerative disease, and sensory impairment. Clinical findings indicate the involvement of the brain in COVID-19, and a diagnosis of dementia represents an important risk factor for mortality in COVID-19 patients. Mechanistic research is needed on SARS-CoV-2 infection and its effects on the nervous system in aging, including individual susceptibility to severe complications from infection, and acute and long-term neurological, neurocognitive, and neurodegenerative sequelae of COVID-19.

Research Objectives

The specific research objectives of this NOSI are to rapidly expand the knowledge base on acute and long-term neurological and neurocognitive sequelae of COVID-19. NIA encourages investigator-initiated new and resubmission applications for research activity codes (i.e., R21, R01, R03) to address significant questions about the neurological and neurocognitive impacts of COVID-19 infection in aging and the interaction in older adults of COVID-19 with comorbid conditions, including Alzheimer’s disease (AD) and AD-related dementia (ADRD). Animal and human studies are appropriate for this NOSI. This NOSI aims to promote collaborative and integrative efforts between investigators with different perspectives and backgrounds.

Funding Opportunity Announcement

NRC Pandemic Response Challenge Program (ongoing)

Details: The NRC will receive $15 million to form dedicated teams to address challenges requiring further research and development for solutions to meet COVID-19 related needs. The NRC will build these teams drawing on internal-to-government capacity and academic researchers who register to indicate their interest, and related areas of expertise and capabilities.

The Pandemic Response Challenge Program is currently structured around 4 main research areas:

  • Rapid detection and diagnosis
  • Therapeutics and vaccines
  • Digital patient care and pandemic analytics
  • Enabling adaptive responses

More information and to register:

Partnership opportunities

IC-Impacts: Innovative Technology Demonstration Projects (ongoing)

Details: IC-IMPACTS is calling for Innovative Technology Demonstration Project proposals on an ongoing basis, relevant to one of IC-IMPACTS’ three themes of safe and sustainable infrastructure, integrated water management, and public health and disease prevention.

IC-IMPACTS is especially inviting proposals within the context of the COVID-19 pandemic. We are working with researchers to develop a comprehensive response strategy, particularly within the Canada-India corridor, a key area of IC-IMPACTS’ focus.

The application must include an industry partner which is committed to the project and can provide both in-kind and cash support. Cash support from industry must be 50% or more of their total support.

Award: $25,000 - $45,000 plus $10,000 in student funding

Full details and application form

NIH Emergency Award: Social, Behavioural and Economic Research on COVID19 Consortium (LOI deadline: October 8, 2021)

Details: The purpose of this FOA is to advance research on the impact of SARS-CoV-2 and associated mitigation efforts on individual, family, and community behavior and on how subsequent economic disruption affects health-related outcomes, with close attention to underserved and vulnerable populations.

To address these questions, this FOA aims to form a research consortium to access, extract, integrate, share, and analyze existing data from various sources with broad population coverage including underserved and vulnerable populations. Examples of existing data include public health data; personal digital data; economic, labor, and commerce data; electronic health records (EHRs); claims data; and ongoing health, demographic, and social surveys. This FOA solicits applications for individual population research projects that will be linked to a Social, Behavioral, and Economic Research on COVID-19 Consortium Coordination Center (SBECCC) to foster collaboration and synergies across consortium member projects.

Note: Foreign institutions are not eligible to lead this application, but can partner as co-applicants with a US-based institution.

Award: up to $500,000/year in direct costs for up to 5 years

Full details